A study published in BMC Cancer sheds light on the self-reported side effects of breast cancer treatment in a low- and middle-income country setting.
The study highlights how these side effects significantly impact the quality of life of patients, emphasizing the need for tailored healthcare strategies.
Breast cancer patients face various underreported or inadequately managed side effects, affecting their overall wellbeing.
The study collected data from 258 individuals treated at major referral hospitals, focusing on treatment toxicities and quality of life using the WHOQOL-BREF assessment tool.
80.2% of participants reported comorbid conditions, complicating cancer management, with worse outcomes seen in patients who underwent mastectomy or had advanced-stage disease.
Side effects ranged from neuropsychiatric symptoms to somatic complaints, impacting physical and mental health during treatment.
The study advocates for personalized care plans considering comorbidities and psychosocial factors to optimize therapeutic efficacy.
It emphasizes the importance of multidisciplinary care involving oncology specialists, mental health professionals, nurses, and social workers for comprehensive support.
Recommendations include community-based support networks, telemedicine for mental health, and patient education programs to enhance patient resilience and coping.
The study calls for policy initiatives and capacity building to address healthcare gaps for breast cancer patients in low- and middle-income countries.